Cord blood transplant for acute myeloid leukaemia

British Journal of Haematology
Karen K Ballen, H M Lazarus

Abstract

Umbilical cord blood is a haematopoietic progenitor cell source for patients with acute myeloid leukaemia (AML), other haematological malignancies and metabolic diseases who can be cured by allogeneic haematopoietic cell transplantation, but who do not have a human leucocyte antigen compatible related or unrelated donor. Although the first cord blood transplants were done in children, there are currently more cord blood transplants performed in adults. In this review, we explore the history of umbilical cord blood transplantation, paediatric and adult outcome results, and novel trends to improve engraftment and reduce infection. Umbilical cord blood transplantation cures approximately 30-40% of adults and 60-70% of children with AML. Controversial issues, including the use of double versus single cord blood units for transplantation, optimal cord blood unit selection, infection prophylaxis, conditioning regimens and graft versus host disease prophylaxis, will be reviewed. Finally, comparison to other graft sources, cost, access to care, and the ideal graft source are discussed.

References

May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H E BroxmeyerE A Boyse
Jul 18, 1996·The New England Journal of Medicine·J KurtzbergP Rubinstein
Jun 16, 2001·The New England Journal of Medicine·M J LaughlinJ Kurtzberg
Jan 16, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Karen K BallenJoseph H Antin
Apr 9, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Julia A Brown, Vassiliki A Boussiotis
Aug 12, 2008·The Lancet Oncology·Francesco FrassoniAndrea Bacigalupo
Dec 2, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jun OoiShigetaka Asano
Aug 8, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jonathan A GutmanColleen Delaney
Nov 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jon J van RoodAndromachi Scaradavou
Jun 19, 2010·The Lancet Oncology·Mary EapenUNKNOWN National Cord Blood Program of the New York Blood Center
Jul 16, 2010·Blood·Minoko TakanashiShunichi Kato
Dec 15, 2010·Blood·Juliet N BarkerAndromachi Scaradavou
Aug 31, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Caron A JacobsonJerome Ritz
Oct 22, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yi-Bin ChenVincent T Ho
Nov 9, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Karen K BallenNavneet S Majhail
Feb 7, 2012·Experimental Hematology·Simon N RobinsonPatrick A Zweidler-McKay
Jul 17, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stefan O CiureaRichard E Champlin
Jul 21, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Vanderson RochaUNKNOWN Eurocord-European Blood and Marrow Transplant Group and the Center for International Blood and Marrow Transplant Research
Dec 14, 2012·The New England Journal of Medicine·Marcos de LimaElizabeth J Shpall
Dec 21, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Takehiko MoriUNKNOWN Kanto Study Group for Cell Therapy
Feb 19, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Shunro KaiShunichi Kato
May 16, 2013·Blood·Karen K BallenHal E Broxmeyer

❮ Previous
Next ❯

Citations

Jul 3, 2019·Japanese Journal of Clinical Oncology·Kittika PoonsombudlertNath Limpruttidham
May 21, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yibo WuYi Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.